CompletedNCT00845273
Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Phase not reported · 3,538 planned enrolment
- Countries listed
- 0
- Registry update
- October 2, 2015
Registry Intervention View
pegaptanib sodium
Trial registrations containing the exact intervention label pegaptanib sodium.
Exact registry label · Not reported
7 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
2 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT00858208
Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
Phase not reported · 86 planned enrolment
- Countries listed
- 1
- Registry update
- April 11, 2012
CompletedNCT00239928
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration
PHASE2 · 61 planned enrolment
- Countries listed
- 1
- Registry update
- May 12, 2011
CompletedNCT00150202
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
PHASE3 · 90 planned enrolment
- Countries listed
- 1
- Registry update
- May 7, 2007
TerminatedNCT00312351
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
PHASE4 · 262 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
CompletedNCT00321997
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.
PHASE2 · PHASE3 · 540 planned enrolment
- Countries listed
- 0
- Registry update
- May 4, 2006
CompletedNCT00088192
Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Phase not reported · planned enrolment not reported
- Countries listed
- 1
- Registry update
- August 30, 2005